Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.6.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JF.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDENSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KE.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HF.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.1.2.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.6.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FD.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCLNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCTNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCKNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.311NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.93NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.104NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.177.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.225NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
AV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.309NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used